Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy.
Adamus
G
G
Amundson
D
D
MacKay
C
C
Gouras
P
P
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000596:Amino Acids / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000032:analysis; D000951:Antigens, Neoplasm / Q000276:immunology*; D001323:Autoantibodies / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis; D002135:Calcium-Binding Proteins / Q000276:immunology*; D002241:Carbohydrates / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004338:Drug Combinations; D016889:Endometrial Neoplasms / Q000150:complications / Q000276:immunology* / Q000628:therapy; D005136:Eye Proteins; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D051597:Hippocalcin; D006801:Humans; D006812:Humic Substances / Q000627:therapeutic use; D008074:Lipoproteins; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009419:Nerve Tissue Proteins; D010257:Paraneoplastic Syndromes / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D051603:Recoverin; D012164:Retinal Diseases / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology; D014574:Uronic Acids / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000596:Amino Acids; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001323:Autoantibodies; D014408:Biomarkers, Tumor; D002135:Calcium-Binding Proteins; D002241:Carbohydrates; D004338:Drug Combinations; D005136:Eye Proteins; D005938:Glucocorticoids; D006812:Humic Substances; D008074:Lipoproteins; D009419:Nerve Tissue Proteins; C496731:RCVRN protein, human; C084029:Tolpa; D014574:Uronic Acids; D051603:Recoverin; D051597:Hippocalcin; D008775:Methylprednisolone